Search

CALL TO ACTION: Help the Ridley Eye Foundation ‘reach more of the unreachable’ in the Himalayas

On the 29 November 1949, Harold Ridley carried out the first implant of an intraocular lens (IoL). This was the first major breakthrough in the cure of cataract blindness since Jacques Daviel conducted the first extra-capsular extraction 198 years earlier....

Low vision support in teenagers

As society places increasing emphasis on mental health and access to technology increases, the structure and prioritisation within low vision appointments is evolving. These changes bring new challenges and demands in terms of our clinical support, requiring us to consider...

Warfarin Induced Suprachoroidal Haemorrhage Presenting as Acute Angle Closure Glaucoma

Spontaneous suprachoroidal haemorrhage is a rare but recognised entity. Anticoagulant therapy is a well known risk factor. We describe a case of warfarin induced suprachoroidal haemorrhage presenting as acute angle closure glaucoma in a patient with raised International Normalised Ratio...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

Improving cataract efficiency: insights and learnings from expert practitioners

An evening surgical meeting sponsored by Théa Pharmaceuticals Ltd brought together leading experts to share insights and experience on practice strategies to enhance the efficiency of cataract surgery. Streamlining patient flow to optimise capacity and efficiency Qasim Mansoor, Consultant Ophthalmic...